I still scratch my head in wonder at ESR's market cap. being 30% more than that of SGQ. Nothing against ESR, but "fair value" for SGQ must surely be at least double the current, if not a treble.
If the current Glycine Leaching testing process can be a cheap way forward to processing our shallow stuff - already known and yet to be discovered, then we must surely be in for one helluva re-rate I reckon!
Kip
Ann: Quarterly Activities and Cashflow Report, page-27
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SGQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
-0.001(2.78%) |
Mkt cap ! $38.09M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.6¢ | 3.5¢ | $95.96K | 2.699M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 121855 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 727058 | 4 |
View Market Depth
| Last trade - 15.27pm 30/09/2024 (20 minute delay) ? |
| SGQ (ASX) Chart |